2019 annual financial data
Avalo Therapeutics 2019 Financial results
Direct answer
Revenue was 6,750,351 USD.
Operating income was -16,137,408 USD and net income was -16,072,547 USD.
Operating cash flow was -19,134,332 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,750,351 USD
- Operating income
- -16,137,408 USD
- Net income
- -16,072,547 USD
- Operating cash flow
- -19,134,332 USD
Explore related company data
View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Avalo Therapeutics financial years